MIR2117HG

Across TCGA pan-cancer cohorts, MIR2117HG RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of MIR2117HG’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where MIR2117HG RNA is repressed in tumor relative to normal tissue. In most cancer types MIR2117HG is over-expressed in tumor, although a few such as THCA and KIRC show the opposite, repressed pattern.

THCA, HNSC, and LIHC are the cancer types where MIR2117HG tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR2117HG RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	III,IV	−1.247	<.001	10	view →
HNSC	All	IV	+1.598	<.001	9	view →
LIHC	All	All	+0.270	<.001	7	view →
LUSC	Female	All	+1.492	<.001	6	view →
LUAD	Male	All	+0.260	<.001	6	view →
BLCA	All	All	+0.890	.010	5	view →
KIRC	All	All	−0.119	.006	3	view →
PRAD	All	All	−0.260	<.001	2	view →
KICH	Male	All	+0.233	.020	2	view →
CHOL	Female	All	−0.206	.016	1	view →
COAD	All	II,III,IV	+0.046	.012	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

MIR2117HG–THCA

Open the THCA breakdown →